Dominican Republic vs Niger: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Dominican Republic
87.0%
in 2025
Niger
87.0%
in 2025
Dominican Republic rank
84th
Niger rank
84th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Dominican Republic
- Niger
How they compare
Dominican Republic currently reports 87.0% against 87.0% in Niger, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Niger ahead.
Dominican Republic ranks 84th and Niger ranks 84th of 192 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 27.6% | 38.3% | 10.7% | Niger |
| 2020s | 79.7% | 84.2% | 4.5% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Dominican Republic or Niger?
- Dominican Republic, at 87.0% against 87.0% in Niger as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Dominican Republic and Niger?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Niger?
- 18 years are reported by both, from 2008 to 2025.
- How do Dominican Republic and Niger rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Dominican Republic ranks 84th and Niger ranks 84th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.